priavoid.com
  • Home
  • About us
    • Overview
    • Strategy
    • Management
    • Supervisory Board
    • Scientific Advisory Board
    • History
  • Drug Development
    • Therapeutic Focus
    • Technology
    • Pipeline
  • Investors and Media
    • News
    • Events
    • Partnering
    • Archive
  • Contact us
    • Careers
Seite wählen

News

Priavoid closes financing round

Priavoid closes financing round

News, Press Release

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

Sprunginnovationsprojekt geht neue Wege in der Alzheimer-Therapie

News, Press Release

Alzheimer´s Research: Important Milestone for PRI-002

Alzheimer´s Research: Important Milestone for PRI-002

News, Press Release

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

Nobel Prize winner Stanley Prusiner joins Priavoid’s supervisory board

News, Press Release

New CEO of Priavoid

New CEO of Priavoid

News

Priavoid Headquarters at LSC Düsseldorf

Priavoid Headquarters at LSC Düsseldorf

News

Seed Investment

Seed Investment

News

Prof. Willbold´s interview with PharmaVentures

Prof. Willbold´s interview with PharmaVentures

News

Clinical trial with PRI-002

Clinical trial with PRI-002

News

Contact us

Please use our contact form if you require any information.

Contact form
  • Home
  • Investors and Media
  • Legal Notice
  • Privacy Policy
  • Contact us
Copyright © 2021 Priavoid GmbH